Literature DB >> 19651473

Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

Kwun Wah Wen1, Blossom Damania.   

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) is a double-stranded DNA herpesvirus belonging to the gamma-herpesvirinae subfamily. KSHV has been associated with the development of three neoplastic diseases: Kaposi sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD). In this review, we discuss the three KSHV-associated malignancies, KSHV genome, latent and lytic aspects of the viral lifecycle, putative viral oncogenes, as well as therapeutic regimens used for the treatment of KS, PEL, and MCD. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2009        PMID： 19651473      PMCID： PMC4342847          DOI： 10.1016/j.canlet.2009.07.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  154 in total

1.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.

Authors:  T Seo; J Park; D Lee; S G Hwang; J Choe
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Immune deficiency and risk for malignancy among persons with AIDS.

Authors:  Sam M Mbulaiteye; Robert J Biggar; James J Goedert; Eric A Engels
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

3.  Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.

Authors:  Michael Pearce; Satoko Matsumura; Angus C Wilson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.

Authors:  Yoshihiro Izumiya; Thomas J Ellison; Edward T H Yeh; Jae U Jung; Paul A Luciw; Hsing-Jien Kung
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.

Authors:  S F Lin; D R Robinson; G Miller; H J Kung
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.

Authors:  Qinmiao Sun; Sunny Zachariah; Preet M Chaudhary
Journal:  J Biol Chem       Date:  2003-10-16       Impact factor: 5.157

Review 8.  Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.

Authors:  Giovanni Stallone; Barbara Infante; Giuseppe Grandaliano; Francesco Paolo Schena; Loreto Gesualdo
Journal:  Transpl Int       Date:  2008-05-22       Impact factor: 3.782

9.  Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.

Authors:  Ling Wang; Blossom Damania
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

10.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor.

Authors:  M Li; H Lee; J Guo; F Neipel; B Fleckenstein; K Ozato; J U Jung
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103
View more
  90 in total

Review 1.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.

Authors:  Deboeeta Chatterjee; Bala Chandran; Edward A Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients.

Authors:  Martina Paradžik; Viljemka Bučević-Popović; Marijan Šitum; Crystal J Jaing; Marina Degoricija; Kevin S McLoughlin; Said I Ismail; Volga Punda-Polić; Janoš Terzić
Journal:  Tumour Biol       Date:  2014-01

Review 4.  The emerging role of triple helices in RNA biology.

Authors:  Nicholas K Conrad
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-09-30       Impact factor: 9.957

5.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

6.  Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation.

Authors:  Fabrizio Angius; Enrica Piras; Sabrina Uda; Clelia Madeddu; Roberto Serpe; Rachele Bigi; Wuguo Chen; Dirk P Dittmer; Raffaello Pompei; Angela Ingianni
Journal:  J Antibiot (Tokyo)       Date:  2017-06-14       Impact factor: 2.649

7.  Human MxB Protein Is a Pan-herpesvirus Restriction Factor.

Authors:  Mirjam Schilling; Lorenzo Bulli; Sebastian Weigang; Laura Graf; Sebastian Naumann; Corinna Patzina; Valentina Wagner; Liane Bauersfeld; Caroline Goujon; Hartmut Hengel; Anne Halenius; Zsolt Ruzsics; Torsten Schaller; Georg Kochs
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

8.  Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.

Authors:  Hyojeung Kang; Paul M Lieberman
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 9.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

10.  K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Authors:  Lisa Steinbrück; Montse Gustems; Stephanie Medele; Thomas F Schulz; Dominik Lutter; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.